Evolent Health (EVH) Misses Q4 EPS by 3c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
Evolent Health (EVH) PT Lowered to $23 at Jefferies
February 27, 2019 2:04 PM ESTJefferies analyst Sean Dodge lowered the price target on Evolent Health (NYSE: EVH) to $23.00 (from $30.00) while maintaining a Buy rating.
... MoreEvolent Health (EVH) PT Lowered to $21 at Oppenheimer Following 4Q
February 27, 2019 9:42 AM ESTOppenheimer analyst Mohan Naidu lowered the price target on Evolent Health (NYSE: EVH) to $21.00 (from $31.00) while maintaining a Outperform rating following the company's 4Q earnings report. EVH reported revenue of $193M vs. consensus of $189M. Adjusted EPS was ($0.07) vs. consensus's ($0.04).
For CY19, EVH... More
